OpenEvidence entered 2026 on an extraordinary growth arc. In January 2026, the Miami-based company closed a $250 Million Series D led by Thrive Capital and DST Global, doubling its valuation to $12 Billion, up from $6 Billion just three months earlier. The round brought total funding raised over the prior 12 months to nearly $700 Million, with backers including Sequoia Capital, Google Ventures (GV), Nvidia, Kleiner Perkins, Craft Ventures, Coatue, Blackstone, ICONIQ, Mayo Cl
Nelson Advisors
Feb 17
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
